FMR LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 310 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$33,939,879
-5.1%
2,622,866
+1.9%
0.00%0.0%
Q1 2024$35,756,197
+15.0%
2,574,240
+18.2%
0.00%0.0%
Q4 2023$31,085,621
-22.5%
2,178,390
-16.0%
0.00%
-33.3%
Q3 2023$40,119,119
+3.1%
2,593,350
+4.7%
0.00%0.0%
Q2 2023$38,919,994
-52.6%
2,477,403
-50.3%
0.00%
-25.0%
Q1 2023$82,169,954
+128.6%
4,986,042
+116.4%
0.00%0.0%
Q4 2022$35,940,525
+37.9%
2,303,880
+14.6%
0.00%
+33.3%
Q3 2022$26,069,000
+0.1%
2,009,910
+8.4%
0.00%0.0%
Q2 2022$26,030,000
-25.8%
1,853,992
-24.3%
0.00%0.0%
Q1 2022$35,058,000
+33.8%
2,448,204
+27.4%
0.00%
+50.0%
Q4 2021$26,199,000
-10.0%
1,922,205
+8.2%
0.00%0.0%
Q3 2021$29,113,000
+11.0%
1,777,325
+14.1%
0.00%0.0%
Q2 2021$26,223,000
+11.6%
1,558,140
+21.1%
0.00%0.0%
Q1 2021$23,489,000
+35.0%
1,286,376
+34.6%
0.00%0.0%
Q4 2020$17,399,000
+3.1%
956,023
+1.1%
0.00%0.0%
Q3 2020$16,875,000
-4.8%
945,894
-4.3%
0.00%0.0%
Q2 2020$17,723,000
+32.1%
988,486
+11.8%
0.00%0.0%
Q1 2020$13,416,000
+22.4%
883,794
+59.1%
0.00%
+100.0%
Q4 2019$10,962,000
+5.3%
555,610
-8.2%
0.00%0.0%
Q3 2019$10,406,000
-78.3%
604,994
-77.7%
0.00%
-83.3%
Q2 2019$47,937,000
-68.9%
2,708,306
-64.2%
0.01%
-66.7%
Q1 2019$154,063,000
+15406200.0%
7,563,259
+9453973.8%
0.02%
Q4 2018$1,000800.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders